- Home
- ACET vs SELF Comparison
ACET vs SELF Comparison
Compare ACET & SELF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACET
- SELF
- Stock Information
- Founded
- ACET 1947
- SELF 1983
- Country
- ACET United States
- SELF United States
- Employees
- ACET N/A
- SELF N/A
- Industry
- ACET Biotechnology: Pharmaceutical Preparations
- SELF Real Estate Investment Trusts
- Sector
- ACET Health Care
- SELF Real Estate
- Exchange
- ACET Nasdaq
- SELF Nasdaq
- Market Cap
- ACET 69.9M
- SELF 57.0M
- IPO Year
- ACET N/A
- SELF N/A
- Fundamental
- Price
- ACET $0.99
- SELF $4.94
- Analyst Decision
- ACET Buy
- SELF
- Analyst Count
- ACET 4
- SELF 0
- Target Price
- ACET $6.00
- SELF N/A
- AVG Volume (30 Days)
- ACET 2.6M
- SELF 35.1K
- Earning Date
- ACET 11-05-2025
- SELF 11-07-2025
- Dividend Yield
- ACET N/A
- SELF 5.84%
- EPS Growth
- ACET N/A
- SELF 9.99
- EPS
- ACET N/A
- SELF 0.22
- Revenue
- ACET N/A
- SELF $12,707,884.00
- Revenue This Year
- ACET N/A
- SELF $2.50
- Revenue Next Year
- ACET N/A
- SELF $1.46
- P/E Ratio
- ACET N/A
- SELF $22.58
- Revenue Growth
- ACET N/A
- SELF 4.08
- 52 Week Low
- ACET $0.45
- SELF $4.73
- 52 Week High
- ACET $1.54
- SELF $5.89
- Technical
- Relative Strength Index (RSI)
- ACET 59.49
- SELF 43.48
- Support Level
- ACET $0.90
- SELF $4.73
- Resistance Level
- ACET $1.07
- SELF $5.01
- Average True Range (ATR)
- ACET 0.10
- SELF 0.08
- MACD
- ACET 0.01
- SELF -0.00
- Stochastic Oscillator
- ACET 65.71
- SELF 67.74
About ACET Adicet Bio Inc.
Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.
About SELF Global Self Storage Inc.
Global Self Storage Inc is a self-administered and self-managed REIT that owns, operates, manages, acquires, develops, and redevelops self-storage properties. The company's self-storage properties are designed to offer affordable, easily accessible, and secure storage space for residential and commercial customers. It has one segment of Rental operations. Through its wholly-owned subsidiaries, the company owns and/or manages close to thirteen self-storage properties in Connecticut, Illinois, Indiana, New York, Ohio, Pennsylvania, South Carolina, and Oklahoma.